cached image

Peter Davies, PhD - Publications

Pathology and Neuroscience Albert Einstein College of Medicine, New York, New York, United States 
Alzheimer's, Apoptosis, Amyloid, Phosphorylation

218 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Jimenez H, Carrion J, Adrien L, Wolin A, Eun J, Cinamon E, Chang EH, Davies P, Vo A, Koppel J. The Impact of Muscarinic Antagonism on Psychosis-Relevant Behaviors and Striatal [C] Raclopride Binding in Tau Mouse Models of Alzheimer's Disease. Biomedicines. 11. PMID 37626588 DOI: 10.3390/biomedicines11082091  0.363
2022 Eun JD, Jimenez H, Adrien L, Wolin A, Marambaud P, Davies P, Koppel JL. Anesthesia promotes acute expression of genes related to Alzheimer's disease and latent tau aggregation in transgenic mouse models of tauopathy. Molecular Medicine (Cambridge, Mass.). 28: 83. PMID 35858831 DOI: 10.1186/s10020-022-00506-4  0.365
2022 Jimenez H, Adrien L, Wolin A, Eun J, Chang EH, Burstein ES, Gomar J, Davies P, Koppel J. The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT- and rTg(P301L)4510 mouse models of Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 8: e12247. PMID 35128032 DOI: 10.1002/trc2.12247  0.305
2022 Alpaugh M, Masnata M, de Rus Jacquet A, Lepinay E, Denis HL, Saint-Pierre M, Davies P, Planel E, Cicchetti F. Passive immunization against phosphorylated tau improves features of Huntington's disease pathology. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 35051614 DOI: 10.1016/j.ymthe.2022.01.020  0.365
2020 Wesseling H, Mair W, Kumar M, Schlaffner CN, Tang S, Beerepoot P, Fatou B, Guise AJ, Cheng L, Takeda S, Muntel J, Rotunno MS, Dujardin S, Davies P, Kosik KS, et al. Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease. Cell. PMID 33188775 DOI: 10.1016/j.cell.2020.10.029  0.575
2020 Goodwin MS, Sinyavskaya O, Burg F, O'Neal V, Ceballos-Diaz C, Cruz PE, Lewis J, Giasson BI, Davies P, Golde TE, Levites Y. Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 33128896 DOI: 10.1016/j.ymthe.2020.10.007  0.34
2020 Xia Y, Prokop S, Gorion KM, Kim JD, Sorrentino ZA, Bell BM, Manaois AN, Chakrabarty P, Davies P, Giasson BI. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies. Acta Neuropathologica Communications. 8: 88. PMID 32571418 DOI: 10.1186/S40478-020-00967-W  0.389
2019 Davidowitz EJ, Krishnamurthy PK, Lopez P, Jimenez H, Adrien L, Davies P, Moe JG. In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice. Journal of Alzheimer's Disease : Jad. PMID 31771053 DOI: 10.3233/JAD-190465  0.34
2017 Rubenstein R, Chang B, Grinkina N, Drummond E, Davies P, Ruditzky M, Sharma D, Wang K, Wisniewski T. Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein. Acta Neuropathologica Communications. 5: 30. PMID 28420443 DOI: 10.1186/S40478-017-0435-7  0.333
2017 Freudenberg-Hua Y, Li W, Ben-Avraham D, Koppel J, Germer S, Darnell R, Barzilai N, Freudenberg J, Atzmon G, Davies P. [P3-118]: INCREASED BURDEN OF RARE LOSS-OF-FUNCTION VARIANTS IN ALZHEIMER's DISEASE PATIENTS COMPARED TO CENTENARIANS Alzheimer's & Dementia. 13: P980-P980. DOI: 10.1016/J.Jalz.2017.06.1329  0.349
2016 Koppel J, Jimenez H, Adrien L, Greenwald BS, Marambaud P, Cinamon E, Davies P. Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 2: 121-130. PMID 29067299 DOI: 10.1016/j.trci.2016.05.003  0.314
2016 Mead E, Kestoras D, Gibson Y, Hamilton L, Goodson R, Jones S, Eversden S, Davies P, O'Neill M, Hutton M, Szekeres P, Wolak J. Halting of Caspase Activity Protects Tau from MC1-Conformational Change and Aggregation. Journal of Alzheimer's Disease : Jad. PMID 27589517 DOI: 10.3233/Jad-150960  0.603
2016 Fu H, Hussaini SA, Wegmann S, Profaci C, Daniels JD, Herman M, Emrani S, Figueroa HY, Hyman BT, Davies P, Duff KE. 3D Visualization of the Temporal and Spatial Spread of Tau Pathology Reveals Extensive Sites of Tau Accumulation Associated with Neuronal Loss and Recognition Memory Deficit in Aged Tau Transgenic Mice. Plos One. 11: e0159463. PMID 27466814 DOI: 10.1371/Journal.Pone.0159463  0.618
2016 Domise M, Didier S, Marinangeli C, Zhao H, Chandakkar P, Buée L, Viollet B, Davies P, Marambaud P, Vingtdeux V. AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo. Scientific Reports. 6: 26758. PMID 27230293 DOI: 10.1038/Srep26758  0.485
2016 Gomar JJ, Conejero-Goldberg C, Davies P, Goldberg TE. Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 26967213 DOI: 10.3233/JAD-150937  0.36
2016 Gomar JJ, Conejero-Goldberg C, Davies P, Goldberg TE. P1-185: Anti-Correlated CSF Biomarker Trajectories in Preclinical Alzheimer’s Disease Alzheimer's & Dementia. 12: P475-P475. DOI: 10.1016/j.jalz.2016.06.933  0.314
2015 Rubenstein R, Chang B, Petersen R, Chiu A, Davies P. T-Tau and P-Tau in Brain and Blood from Natural and Experimental Prion Diseases. Plos One. 10: e0143103. PMID 26630676 DOI: 10.1371/Journal.Pone.0143103  0.412
2015 d'Abramo C, Acker CM, Schachter JB, Terracina G, Wang X, Forest SK, Davies P. Detecting tau in serum of transgenic animal models after tau immunotherapy treatment. Neurobiology of Aging. PMID 26508157 DOI: 10.1016/J.Neurobiolaging.2015.09.017  0.784
2015 Conejero-Goldberg C, Hyde TM, Chen S, Herman MM, Kleinman JE, Davies P, Goldberg TE. Cortical Transcriptional Profiles in APOE4 Carriers with Alzheimer's Disease: Patterns of Protection and Degeneration. Journal of Alzheimer's Disease : Jad. PMID 26444771 DOI: 10.3233/JAD-150345  0.314
2015 Spiegel J, Pirraglia E, Li Y, Tsui W, Glodzik L, Osorio RS, Saint Louis LA, Randall C, Butler T, Xu J, Zinkowski RP, Zetterberg H, Fortea J, Fossati S, Wisniewski T, ... Davies P, et al. Greater Specificity for Cerebrospinal Fluid P-tau231 over P-tau181 in the Differentiation of Healthy Controls from Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 26444757 DOI: 10.3233/Jad-150167  0.399
2015 Sottejeau Y, Bretteville A, Cantrelle FX, Malmanche N, Demiaute F, Mendes T, Delay C, Alves Dos Alves H, Flaig A, Davies P, Dourlen P, Dermaut B, Laporte J, Amouyel P, Lippens G, et al. Tau phosphorylation regulates the interaction between BIN1's SH3 domain and Tau's proline-rich domain. Acta Neuropathologica Communications. 3: 58. PMID 26395440 DOI: 10.1186/S40478-015-0237-8  0.45
2014 Koppel J, Acker C, Davies P, Lopez OL, Jimenez H, Azose M, Greenwald BS, Murray PS, Kirkwood CM, Kofler J, Sweet RA. Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities. Neurobiology of Aging. 35: 2021-8. PMID 24731519 DOI: 10.1016/J.Neurobiolaging.2014.03.003  0.323
2014 Koppel J, Sunday S, Goldberg TE, Davies P, Christen E, Greenwald BS. Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 22: 698-707. PMID 23672944 DOI: 10.1016/J.Jagp.2012.10.028  0.421
2013 Koppel J, Sunday S, Buthorn J, Goldberg T, Davies P, Greenwald B. Elevated CSF Tau is associated with psychosis in Alzheimer's disease. The American Journal of Psychiatry. 170: 1212-3. PMID 24084821 DOI: 10.1176/Appi.Ajp.2013.13040466  0.446
2013 Cavallini A, Brewerton S, Bell A, Sargent S, Glover S, Hardy C, Moore R, Calley J, Ramachandran D, Poidinger M, Karran E, Davies P, Hutton M, Szekeres P, Bose S. An unbiased approach to identifying tau kinases that phosphorylate tau at sites associated with Alzheimer disease. The Journal of Biological Chemistry. 288: 23331-47. PMID 23798682 DOI: 10.1074/jbc.M113.463984  0.657
2013 d'Abramo C, Acker CM, Jimenez HT, Davies P. Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity. Plos One. 8: e62402. PMID 23638068 DOI: 10.1371/journal.pone.0062402  0.315
2013 Dreses-Werringloer U, Vingtdeux V, Zhao H, Chandakkar P, Davies P, Marambaud P. CALHM1 controls the Ca²⁺-dependent MEK, ERK, RSK and MSK signaling cascade in neurons. Journal of Cell Science. 126: 1199-206. PMID 23345406 DOI: 10.1242/jcs.117135  0.307
2013 Forest SK, Acker CM, d'Abramo C, Davies P. Methods for measuring tau pathology in transgenic mouse models. Journal of Alzheimer's Disease : Jad. 33: 463-71. PMID 22976073 DOI: 10.3233/Jad-2012-121354  0.793
2013 Acker CM, Forest SK, Zinkowski R, Davies P, d'Abramo C. Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models. Neurobiology of Aging. 34: 338-50. PMID 22727277 DOI: 10.1016/J.Jalz.2012.05.1222  0.814
2012 Dai M, Freeman B, Shikani HJ, Bruno FP, Collado JE, Macias R, Reznik SE, Davies P, Spray DC, Tanowitz HB, Weiss LM, Desruisseaux MS. Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment. Plos One. 7: e44117. PMID 23082110 DOI: 10.1371/Journal.Pone.0044117  0.306
2012 Gordon ML, Kingsley PB, Goldberg TE, Koppel J, Christen E, Keehlisen L, Kohn N, Davies P. An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders Extra. 2: 312-20. PMID 22962555 DOI: 10.1159/000341604  0.33
2012 Schlatterer SD, Suh HS, Conejero-Goldberg C, Chen S, Acker CM, Lee SC, Davies P. Neuronal c-Abl activation leads to induction of cell cycle and interferon signaling pathways. Journal of Neuroinflammation. 9: 208. PMID 22938163 DOI: 10.1186/1742-2094-9-208  0.752
2012 Weinger JG, Davies P, Acker CM, Brosnan CF, Tsiperson V, Bayewitz A, Shafit-Zagardo B. Mice devoid of Tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. Journal of Neuropathology and Experimental Neurology. 71: 422-33. PMID 22487860 DOI: 10.1097/Nen.0B013E3182540D2E  0.401
2012 Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. Journal of Neuropathology and Experimental Neurology. 71: 362-81. PMID 22487856 DOI: 10.1097/Nen.0B013E31825018F7  0.667
2012 Capiralla H, Vingtdeux V, Zhao H, Sankowski R, Al-Abed Y, Davies P, Marambaud P. Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade. Journal of Neurochemistry. 120: 461-72. PMID 22118570 DOI: 10.1111/J.1471-4159.2011.07594.X  0.32
2012 Chapuis J, Vingtdeux V, Capiralla H, Davies P, Marambaud P. Gas1 interferes with AβPP trafficking by facilitating the accumulation of immature AβPP in endoplasmic reticulum-associated raft subdomains. Journal of Alzheimer's Disease : Jad. 28: 127-35. PMID 21971401 DOI: 10.3233/JAD-2011-110434  0.317
2012 Davies P. Characterization and use of monoclonal antibodies to tau and paired helical filament tau. Methods in Molecular Medicine. 32: 361-73. PMID 21318532 DOI: 10.1385/1-59259-195-7:361  0.433
2012 Forest S, Acker C, Davies P. P3-023: Quantitative methods for evaluation of tau pathology Alzheimer's & Dementia. 8: P462-P462. DOI: 10.1016/J.Jalz.2012.05.1241  0.75
2011 Chai X, Wu S, Murray TK, Kinley R, Cella CV, Sims H, Buckner N, Hanmer J, Davies P, O'Neill MJ, Hutton ML, Citron M. Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression. The Journal of Biological Chemistry. 286: 34457-67. PMID 21841002 DOI: 10.1074/jbc.M111.229633  0.642
2011 Schlatterer SD, Acker CM, Davies P. c-Abl in neurodegenerative disease. Journal of Molecular Neuroscience : Mn. 45: 445-52. PMID 21728062 DOI: 10.1007/S12031-011-9588-1  0.754
2011 Boutajangout A, Ingadottir J, Davies P, Sigurdsson EM. Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain. Journal of Neurochemistry. 118: 658-67. PMID 21644996 DOI: 10.1111/j.1471-4159.2011.07337.x  0.341
2011 Koppel J, Campagne F, Vingtdeux V, Dreses-Werringloer U, Ewers M, Rujescu D, Hampel H, Gordon ML, Christen E, Chapuis J, Greenwald BS, Davies P, Marambaud P. CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease. Molecular Medicine (Cambridge, Mass.). 17: 974-9. PMID 21629967 DOI: 10.2119/molmed.2011.00154  0.392
2011 Schlatterer SD, Tremblay MA, Acker CM, Davies P. Neuronal c-Abl overexpression leads to neuronal loss and neuroinflammation in the mouse forebrain. Journal of Alzheimer's Disease : Jad. 25: 119-33. PMID 21368377 DOI: 10.3233/Jad-2011-102025  0.772
2011 Chapuis J, Vingtdeux V, Campagne F, Davies P, Marambaud P. Growth arrest-specific 1 binds to and controls the maturation and processing of the amyloid-beta precursor protein. Human Molecular Genetics. 20: 2026-36. PMID 21357679 DOI: 10.1093/hmg/ddr085  0.382
2011 Vingtdeux V, Davies P, Dickson DW, Marambaud P. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies. Acta Neuropathologica. 121: 337-49. PMID 20957377 DOI: 10.1007/S00401-010-0759-X  0.374
2011 Schlatterer S, Acker C, Davies P. P3-040: Elevation of inflammatory markers precedes development of neuroinflammatory pathology and neuronal loss in mice expressing constitutively active c-Abl in forebrain Alzheimer's & Dementia. 7: S527-S527. DOI: 10.1016/J.Jalz.2011.05.1479  0.73
2011 Vingtdeux V, Davies P, Chambwe N, Dreses-Werringloer U, Chapuis J, Koppel J, Campagne F, Marambaud P. O3-04-05: Generation and characterization of a CALHM1 knockout mouse model: Relevance for Alzheimer's disease Alzheimer's & Dementia. 7: S506-S506. DOI: 10.1016/j.jalz.2011.05.1412  0.355
2010 Vingtdeux V, Chandakkar P, Zhao H, d'Abramo C, Davies P, Marambaud P. Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 219-31. PMID 20852062 DOI: 10.1096/fj.10-167361  0.328
2010 Giliberto L, d'Abramo C, Acker CM, Davies P, D'Adamio L. Transgenic expression of the amyloid-beta precursor protein-intracellular domain does not induce Alzheimer's Disease-like traits in vivo. Plos One. 5: e11609. PMID 20661273 DOI: 10.1371/Journal.Pone.0011609  0.378
2010 Tremblay MA, Acker CM, Davies P. Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase, Arg. Journal of Alzheimer's Disease : Jad. 19: 721-33. PMID 20110615 DOI: 10.3233/JAD-2010-1271  0.459
2010 Rojo LE, Alzate-Morales J, Saavedra IN, Davies P, Maccioni RB. Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 19: 573-89. PMID 20110603 DOI: 10.3233/JAD-2010-1262  0.444
2010 Vingtdeux V, Giliberto L, Zhao H, Chandakkar P, Wu Q, Simon JE, Janle EM, Lobo J, Ferruzzi MG, Davies P, Marambaud P. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. The Journal of Biological Chemistry. 285: 9100-13. PMID 20080969 DOI: 10.1074/Jbc.M109.060061  0.377
2010 Szekeres PG, Glover SJ, Lakics V, Cella CV, Purcell R, Murray TK, Cavallini A, Lavenir I, Goedert M, Davies P, Hutton ML, O'Neill MJ. Dramatic increases in phosphorylation of tau only on specific epitopes correlates with decline in motor function in aged P301S mice Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.901  0.349
2010 Goldgaber D, Davies P, Gambetti P, Walker LC, Friedland RP, White LR, Piccardo P, Asher DM. P1-263: Transmission of Alzheimer amyloidosis to chimpanzees and monkeys: Revisited Alzheimer's & Dementia. 6: S250-S250. DOI: 10.1016/J.Jalz.2010.05.815  0.342
2010 Schlatterer SD, Tremblay MA, Acker CM, Davies P. P1-160: Neurodegeneration as a consequence of expression of active c-abl in the adult mouse brain Alzheimer's & Dementia. 6: S220-S220. DOI: 10.1016/J.Jalz.2010.05.710  0.732
2010 Conejero-Goldberg C, Hyde TM, Chen S, Dreses-Werringloer U, Herman MM, Kleinman JE, Davies P, Goldberg TE. Molecular signatures in post mortem brain tissue of individuals at high risk for Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.619  0.349
2010 Boutajangout A, Ingadottir J, Davies P, Sigurdsson EM. P3-427: Passive tau immunotherapy diminishes functional decline and clears tau aggregates in a mouse model of tauopathy Alzheimer's & Dementia. 6: S578-S578. DOI: 10.1016/j.jalz.2010.05.1970  0.406
2009 Polydoro M, Acker CM, Duff K, Castillo PE, Davies P. Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 10741-9. PMID 19710325 DOI: 10.1523/Jneurosci.1065-09.2009  0.768
2009 Hu S, Begum AN, Jones MR, Oh MS, Beech WK, Beech BH, Yang F, Chen P, Ubeda OJ, Kim PC, Davies P, Ma Q, Cole GM, Frautschy SA. GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals. Neurobiology of Disease. 33: 193-206. PMID 19038340 DOI: 10.1016/j.nbd.2008.10.007  0.415
2009 Polydoro M, Acker CM, Duff K, Castillo PE, Davies P. O4-03-01: Age-dependent impairment of cognitive and synaptic function in transgenic mouse model of tau pathology (htau mouse) Alzheimer's & Dementia. 5: P153-P154. DOI: 10.1016/J.Jalz.2009.05.531  0.752
2009 Conejero-Goldberg C, Hyde TM, Chen S, Dreses-Werringloer U, Herman M, Kleinman JE, Davies P, Goldberg T. Molecular signature of prodromal Alzheimer's disease: A microarray study in post-mortem cortical tissue Alzheimers & Dementia. 5: 305. DOI: 10.1016/J.Jalz.2009.04.460  0.358
2008 Planel E, Krishnamurthy P, Miyasaka T, Liu L, Herman M, Kumar A, Bretteville A, Figueroa HY, Yu WH, Whittington RA, Davies P, Takashima A, Nixon RA, Duff KE. Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 12798-807. PMID 19036972 DOI: 10.1523/Jneurosci.4101-08.2008  0.422
2008 Dreses-Werringloer U, Lambert JC, Vingtdeux V, Zhao H, Vais H, Siebert A, Jain A, Koppel J, Rovelet-Lecrux A, Hannequin D, Pasquier F, Galimberti D, Scarpini E, Mann D, Lendon C, ... ... Davies P, et al. A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk. Cell. 133: 1149-61. PMID 18585350 DOI: 10.1016/J.Cell.2008.05.048  0.345
2008 Espinoza M, de Silva R, Dickson DW, Davies P. Differential incorporation of tau isoforms in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 14: 1-16. PMID 18525123 DOI: 10.3233/Jad-2008-14101  0.467
2008 Crystal HA, Davies P. Toward a plasma marker for Alzheimer disease: some progress, but still a long way to go. Neurology. 70: 586-7. PMID 18285532 DOI: 10.1212/01.wnl.0000299905.05595.68  0.353
2008 Conejero-Goldberg C, Townsend K, Davies P. Effects of cell cycle inhibitors on tau phosphorylation in N2aTau3R cells. Journal of Molecular Neuroscience : Mn. 35: 143-50. PMID 18278567 DOI: 10.1007/s12031-008-9044-z  0.418
2008 Marambaud P, Dreses-Werringloer U, Lambert J, Vingtdeux V, Zhao H, Koppel J, Pasquier F, Mann D, Lendon C, Amouyel P, Foskett JK, Campagne F, Davies P. O4-06-06: The calcium homeostasis modulator CALHM1 controls Abeta levels and Alzheimer's disease risk Alzheimer's & Dementia. 4: T197-T197. DOI: 10.1016/J.Jalz.2008.05.550  0.314
2008 Dreses-Werringloer U, Lambert J, Vingtdeux V, Zhao H, Vais H, Siebert A, Jain A, Koppel J, Pasquier F, Mann D, Lendon C, Amouyel P, Davies P, Foskett JK, Campagne F, et al. P4-245: The Alzheimer's disease susceptibility gene CALHM1 encodes a brain calcium channel Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2313  0.33
2007 Conejero-Goldberg C, Davies P, Ulloa L. Alpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration. Neuroscience and Biobehavioral Reviews. 32: 693-706. PMID 18180036 DOI: 10.1016/j.neubiorev.2007.10.007  0.389
2007 Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Annals of Neurology. 61: 435-45. PMID 17469117 DOI: 10.1002/Ana.21154  0.62
2007 Park KH, Hallows JL, Chakrabarty P, Davies P, Vincent I. Conditional neuronal simian virus 40 T antigen expression induces Alzheimer-like tau and amyloid pathology in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 2969-78. PMID 17360920 DOI: 10.1523/Jneurosci.0186-07.2007  0.454
2007 Josephs KA, Ahmed Z, Katsuse O, Parisi JF, Boeve BF, Knopman DS, Petersen RC, Davies P, Duara R, Graff-Radford NR, Uitti RJ, Rademakers R, Adamson J, Baker M, Hutton ML, et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. Journal of Neuropathology and Experimental Neurology. 66: 142-51. PMID 17278999 DOI: 10.1097/Nen.0B013E31803020Cf  0.535
2007 Haroutunian V, Davies P, Vianna C, Buxbaum JD, Purohit DP. Tau protein abnormalities associated with the progression of alzheimer disease type dementia. Neurobiology of Aging. 28: 1-7. PMID 16343696 DOI: 10.1016/J.Neurobiolaging.2005.11.001  0.463
2006 Davies P. A long trek down the pathways of cell death in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 9: 265-9. PMID 16914865 DOI: 10.3233/JAD-2006-9S329  0.357
2006 Siegel DA, Davies P, Dobrenis K, Huang M. Tomoregulin-2 is found extensively in plaques in Alzheimer's disease brain. Journal of Neurochemistry. 98: 34-44. PMID 16805794 DOI: 10.1111/j.1471-4159.2006.03801.x  0.44
2006 d'Abramo C, Ricciarelli R, Pronzato MA, Davies P. Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cells. Journal of Neurochemistry. 98: 1068-77. PMID 16787414 DOI: 10.1111/j.1471-4159.2006.03931.x  0.418
2006 Herskovits AZ, Davies P. The regulation of tau phosphorylation by PCTAIRE 3: implications for the pathogenesis of Alzheimer's disease. Neurobiology of Disease. 23: 398-408. PMID 16766195 DOI: 10.1016/J.Nbd.2006.04.004  0.827
2006 de Silva R, Lashley T, Strand C, Shiarli AM, Shi J, Tian J, Bailey KL, Davies P, Bigio EH, Arima K, Iseki E, Murayama S, Kretzschmar H, Neumann M, Lippa C, et al. An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies. Acta Neuropathologica. 111: 329-40. PMID 16552612 DOI: 10.1007/S00401-006-0048-X  0.393
2006 Cripps D, Thomas SN, Jeng Y, Yang F, Davies P, Yang AJ. Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation. The Journal of Biological Chemistry. 281: 10825-38. PMID 16443603 DOI: 10.1074/Jbc.M512786200  0.471
2006 Tremblay M, Davies P. P3-330: Tyrosine phosphorylation of tau by Abl2 (ARG) Alzheimer's & Dementia. 2: S471-S472. DOI: 10.1016/j.jalz.2006.05.1600  0.369
2005 Andorfer C, Acker CM, Kress Y, Hof PR, Duff K, Davies P. Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 5446-54. PMID 15930395 DOI: 10.1523/Jneurosci.4637-04.2005  0.8
2005 Hampel H, Bürger K, Pruessner JC, Zinkowski R, DeBernardis J, Kerkman D, Leinsinger G, Evans AC, Davies P, Möller HJ, Teipel SJ. Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease. Archives of Neurology. 62: 770-3. PMID 15883264 DOI: 10.1001/archneur.62.5.770  0.449
2005 Herskovits AZ, Davies P. Generation and characterization of monoclonal antibodies to human PCTAIRE 3. Hybridoma (2005). 24: 98-105. PMID 15857174 DOI: 10.1089/Hyb.2005.24.98  0.755
2005 Fujino Y, Wang DS, Thomas N, Espinoza M, Davies P, Dickson DW. Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry. Journal of Neuropathology and Experimental Neurology. 64: 209-14. PMID 15804052 DOI: 10.1093/Jnen/64.3.209  0.416
2005 Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, Goldstein LS. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science (New York, N.Y.). 307: 1282-8. PMID 15731448 DOI: 10.1126/Science.1105681  0.359
2005 Tchaikovskaya T, Fraifeld V, Urphanishvili T, Andorfer JH, Davies P, Listowsky I. Glutathione S-transferase hGSTM3 and ageing-associated neurodegeneration: relationship to Alzheimer's disease. Mechanisms of Ageing and Development. 126: 309-315. PMID 15621212 DOI: 10.1016/J.Mad.2004.08.029  0.378
2004 Lovell MA, Xiong S, Xie C, Davies P, Markesbery WR. Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. Journal of Alzheimer's Disease : Jad. 6: 659-71; discussion 6. PMID 15665406 DOI: 10.3233/Jad-2004-6610  0.392
2004 Fujino Y, DeLucia MW, Davies P, Dickson DW. Ballooned neurones in the limbic lobe are associated with Alzheimer type pathology and lack diagnostic specificity Neuropathology and Applied Neurobiology. 30: 676-682. PMID 15541007 DOI: 10.1111/J.1365-2990.2004.00593.X  0.422
2004 Yao J, Petanceska SS, Montine TJ, Holtzman DM, Schmidt SD, Parker CA, Callahan MJ, Lipinski WJ, Bisgaier CL, Turner BA, Nixon RA, Martins RN, Ouimet C, Smith JD, Davies P, et al. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits. Journal of Neurochemistry. 90: 1011-8. PMID 15287908 DOI: 10.1111/J.1471-4159.2004.02532.X  0.373
2004 Herskovits AZ, Davies P. Cloning and expression analysis of two novel PCTAIRE 3 transcripts from human brain. Gene. 328: 59-67. PMID 15019984 DOI: 10.1016/J.Gene.2003.12.011  0.735
2004 Hampel H, Buerger K, Zinkowski R, Teipel SJ, Goernitz A, Andreasen N, Sjoegren M, DeBernardis J, Kerkman D, Ishiguro K, Ohno H, Vanmechelen E, Vanderstichele H, McCulloch C, Moller HJ, ... Davies P, et al. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study. Archives of General Psychiatry. 61: 95-102. PMID 14706948 DOI: 10.1001/archpsyc.61.1.95  0.467
2004 Andorfer CA, Acker CM, Kress Y, Duff K, Davies P. P2-078 Neurofibrillary tangles and cell death in transgenic mice expressing non-mutant human isoforms of TAU Neurobiology of Aging. 25: S246. DOI: 10.1016/S0197-4580(04)80825-X  0.775
2004 de Leon MJ, Santi SD, Zinkowski R, Mehta P, Pratico D, Segal S, Rusinek H, Li J, Tsui W, Louis LS, Clark C, Tarshish C, Lair L, Javier E, Lesbre P, ... ... Davies P, et al. O2-01-01 Biomarkers for Alzheimer's disease improve early diagnosis Neurobiology of Aging. 25: S33-S34. DOI: 10.1016/S0197-4580(04)80111-8  0.333
2003 Ramakrishnan P, Dickson DW, Davies P. Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies. Neurobiology of Disease. 14: 251-64. PMID 14572447 DOI: 10.1016/S0969-9961(03)00109-8  0.719
2003 Scheinfeld MH, Ghersi E, Davies P, D'Adamio L. Amyloid beta protein precursor is phosphorylated by JNK-1 independent of, yet facilitated by, JNK-interacting protein (JIP)-1. The Journal of Biological Chemistry. 278: 42058-63. PMID 12917434 DOI: 10.1074/Jbc.M304853200  0.408
2003 Hogg M, Grujic ZM, Baker M, Demirci S, Guillozet AL, Sweet AP, Herzog LL, Weintraub S, Mesulam MM, LaPointe NE, Gamblin TC, Berry RW, Binder LI, de Silva R, Lees A, ... ... Davies P, et al. The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy. Acta Neuropathologica. 106: 323-36. PMID 12883828 DOI: 10.1007/S00401-003-0734-X  0.593
2003 Andorfer C, Kress Y, Espinoza M, de Silva R, Tucker KL, Barde YA, Duff K, Davies P. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. Journal of Neurochemistry. 86: 582-90. PMID 12859672 DOI: 10.1046/J.1471-4159.2003.01879.X  0.82
2003 Tandon A, Yu H, Wang L, Rogaeva E, Sato C, Chishti MA, Kawarai T, Hasegawa H, Chen F, Davies P, Fraser PE, Westaway D, St George-Hyslop PH. Brain levels of CDK5 activator p25 are not increased in Alzheimer's or other neurodegenerative diseases with neurofibrillary tangles. Journal of Neurochemistry. 86: 572-81. PMID 12859671 DOI: 10.1046/J.1471-4159.2003.01865.X  0.412
2003 Noble W, Olm V, Takata K, Casey E, Mary O, Meyerson J, Gaynor K, LaFrancois J, Wang L, Kondo T, Davies P, Burns M, Veeranna, Nixon R, Dickson D, et al. Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron. 38: 555-65. PMID 12765608 DOI: 10.1016/S0896-6273(03)00259-9  0.472
2003 Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. Journal of Neuropathology and Experimental Neurology. 62: 389-97. PMID 12722831 DOI: 10.1093/Jnen/62.4.389  0.425
2002 de Leon MJ, Segal S, Tarshish CY, DeSanti S, Zinkowski R, Mehta PD, Convit A, Caraos C, Rusinek H, Tsui W, Saint Louis LA, DeBernardis J, Kerkman D, Qadri F, Gary A, ... ... Davies P, et al. Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment. Neuroscience Letters. 333: 183-6. PMID 12429378 DOI: 10.1016/S0304-3940(02)01038-8  0.435
2002 Buerger K, Teipel SJ, Zinkowski R, Blennow K, Arai H, Engel R, Hofmann-Kiefer K, McCulloch C, Ptok U, Heun R, Andreasen N, DeBernardis J, Kerkman D, Moeller H, Davies P, et al. CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects. Neurology. 59: 627-9. PMID 12196665 DOI: 10.1212/WNL.59.4.627  0.379
2002 Buerger K, Zinkowski R, Teipel SJ, Tapiola T, Arai H, Blennow K, Andreasen N, Hofmann-Kiefer K, DeBernardis J, Kerkman D, McCulloch C, Kohnken R, Padberg F, Pirttilä T, Schapiro MB, ... ... Davies P, et al. Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Archives of Neurology. 59: 1267-72. PMID 12164722 DOI: 10.1001/Archneur.59.8.1267  0.464
2002 Conrad C, Vianna C, Freeman M, Davies P. A polymorphic gene nested within an intron of the tau gene: implications for Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 99: 7751-6. PMID 12032355 DOI: 10.1073/pnas.112194599  0.361
2002 Bu B, Li J, Davies P, Vincent I. Deregulation of cdk5, Hyperphosphorylation, and Cytoskeletal Pathology in the Niemann–Pick Type C Murine Model The Journal of Neuroscience. 22: 6515-6525. DOI: 10.1523/JNEUROSCI.22-15-06515.2002  0.401
2002 Hampel H, Bürger K, Zinkowski R, Teipel S, Kohnken R, Kerkman D, DeBernardis J, Kahle P, Rapoport S, Sunderland T, Arai H, Tapiola T, Hoffmann-Kiefer K, Andreasen N, Blennow K, ... ... Davies P, et al. CSF tau phosphorylated at threonine 231, total tau and neuronal thread protein in the diagnosis of Alzheimer's disease European Psychiatry. 17: 77. DOI: 10.1016/S0924-9338(02)80352-2  0.471
2001 Parvathy S, Davies P, Haroutunian V, Purohit DP, Davis KL, Mohs RC, Park H, Moran TM, Chan JY, Buxbaum JD. Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline. Archives of Neurology. 58: 2025-32. PMID 11735776 DOI: 10.1001/Archneur.58.12.2025  0.372
2001 Dranovsky A, Vincent I, Gregori L, Schwarzman A, Colflesh D, Enghild J, Strittmatter W, Davies P, Goldgaber D. Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology. Neurobiology of Aging. 22: 517-28. PMID 11445251 DOI: 10.1016/S0197-4580(00)00248-7  0.43
2001 Bigio EH, Lipton AM, Yen SH, Hutton ML, Baker M, Nacharaju P, White CL, Davies P, Lin W, Dickson DW. Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia. Journal of Neuropathology and Experimental Neurology. 60: 328-41. PMID 11305868 DOI: 10.1093/Jnen/60.4.328  0.641
2001 Davies P. A very incomplete comprehensive theory of Alzheimer's disease. Annals of the New York Academy of Sciences. 924: 8-16. PMID 11193806 DOI: 10.1111/j.1749-6632.2000.tb05553.x  0.318
2001 Hampel H, Buerger K, Kohnken R, Teipel SJ, Zinkowski R, Moeller H, Rapoport SI, Davies P. Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231 Annals of Neurology. 49: 545-546. DOI: 10.1002/Ana.111  0.436
2000 Weaver CL, Espinoza M, Kress Y, Davies P. Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiology of Aging. 21: 719-27. PMID 11016541 DOI: 10.1016/S0197-4580(00)00157-3  0.775
2000 Ishizawa K, Ksiezak-Reding H, Davies P, Delacourte A, Tiseo P, Yen SH, Dickson DW. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease. Acta Neuropathologica. 100: 235-44. PMID 10965792 DOI: 10.1007/S004019900177  0.479
2000 Andorfer CA, Davies P. PKA phosphorylations on tau: developmental studies in the mouse. Developmental Neuroscience. 22: 303-9. PMID 10965152 DOI: 10.1159/000017454  0.795
2000 Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn-Hardy K, Paul Murphy M, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin WL, Yen SH, ... ... Davies P, et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nature Genetics. 25: 402-5. PMID 10932182 DOI: 10.1038/78078  0.654
2000 Kohnken R, Buerger K, Zinkowski R, Miller C, Kerkman D, DeBernardis J, Shen J, Möller HJ, Davies P, Hampel H. Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients. Neuroscience Letters. 287: 187-90. PMID 10863026 DOI: 10.1016/S0304-3940(00)01178-2  0.43
2000 Ishizawa K, Lin WL, Tiseo P, Honer WG, Davies P, Dickson DW. A qualitative and quantitative study of grumose degeneration in progressive supranuclear palsy. Journal of Neuropathology and Experimental Neurology. 59: 513-24. PMID 10850864 DOI: 10.1093/Jnen/59.6.513  0.316
2000 Crystal HA, Dickson D, Davies P, Masur D, Grober E, Lipton RB. The relative frequency of 'dementia of unknown etiology' increases with age and is nearly 50% in nonagenarians Archives of Neurology. 57: 713-719. PMID 10815138 DOI: 10.1001/Archneur.57.5.713  0.364
2000 Duff K, Knight H, Refolo LM, Sanders S, Yu X, Picciano M, Malester B, Hutton M, Adamson J, Goedert M, Burki K, Davies P. Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes. Neurobiology of Disease. 7: 87-98. PMID 10783293 DOI: 10.1006/Nbdi.1999.0279  0.628
2000 Näslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, Buxbaum JD. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. Jama. 283: 1571-7. PMID 10735393 DOI: 10.1001/Jama.283.12.1571  0.404
2000 Davies P, Andorfer C, Weaver CL, Stahl M, Espinzona M, DeBernardis J. APP and tau phosphorylation in early Alzheimer's disease Neurobiology of Aging. 21: 210-211. DOI: 10.1016/S0197-4580(00)83276-5  0.816
2000 Bussiere T, Wicinski BA, Lin GI, Perl DP, Davies P, Nixon RA, Morrison JH, Hof PR. Stereologic analysis of vulnerable neocortical neurons in normal aging and Alzheimer's disease Neurobiology of Aging. 21: 24-25. DOI: 10.1016/S0197-4580(00)82787-6  0.382
2000 Duff K, Refolo LM, Hutton M, Davies P. Tau pathobiology in transgenic mouse models Neurobiology of Aging. 21: 76. DOI: 10.1016/S0197-4580(00)82565-8  0.614
2000 Lewis J, Davies P, Yen S, Dickson DW, Hutton M. Neurofibrillary tangles, neuronal loss, and severe motor changes develop in transgenic mice expressing tau (4R0N) with the frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) mutation P301L Neurobiology of Aging. 21: 59. DOI: 10.1016/S0197-4580(00)82491-4  0.601
2000 Kohnken RE, Buerger K, Zinkowski R, Kerkman D, DeBernardis J, Shen J, Davies P, Hampel H. Detection of tau phosphorylated at theonine 231 in human brain extracts and cerebrospinal fluid Neurobiology of Aging. 21: 165. DOI: 10.1016/S0197-4580(00)82078-3  0.357
1999 Jicha GA, Weaver C, Lane E, Vianna C, Kress Y, Rockwood J, Davies P. cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 7486-94. PMID 10460255 DOI: 10.1523/Jneurosci.19-17-07486.1999  0.794
1999 Lu PJ, Wulf G, Zhou XZ, Davies P, Lu KP. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature. 399: 784-8. PMID 10391244 DOI: 10.1038/21650  0.471
1999 Jicha GA, Berenfeld B, Davies P. Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease. Journal of Neuroscience Research. 55: 713-23. PMID 10220112 DOI: 10.1002/(Sici)1097-4547(19990315)55:6<713::Aid-Jnr6>3.0.Co;2-G  0.658
1999 Davies P. Challenging the cholinergic hypothesis in Alzheimer disease Journal of the American Medical Association. 281: 1433-1434. PMID 10217061 DOI: 10.1001/jama.281.15.1433  0.403
1999 Houlden H, Rizzu P, Stevens M, de Knijff P, van Duijn CM, van Swieten JC, Heutink P, Perez-Tur J, Thomas V, Baker M, Morris H, Rossor M, Jannsen JC, Petersen RC, Dodd P, ... ... Davies P, et al. Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutations. Neuroscience Letters. 260: 193-5. PMID 10076900 DOI: 10.1016/S0304-3940(98)00931-8  0.388
1999 Jicha GA, Rockwood JM, Berenfeld B, Hutton M, Davies P. Altered conformation of recombinant frontotemporal dementia-17 mutant tau proteins. Neuroscience Letters. 260: 153-6. PMID 10076890 DOI: 10.1016/S0304-3940(98)00980-X  0.705
1998 Vincent I, Zheng JH, Dickson DW, Kress Y, Davies P. Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiology of Aging. 19: 287-96. PMID 9733160 DOI: 10.1016/S0197-4580(98)00071-2  0.481
1998 Davies P, Anderton B, Kirsch J, Konnerth A, Nitsch R, Sheetz M. First one in, last one out: the role of gabaergic transmission in generation and degeneration. Progress in Neurobiology. 55: 651-8. PMID 9670223 DOI: 10.1016/S0301-0082(98)00024-0  0.321
1998 Anderton BH, Callahan L, Coleman P, Davies P, Flood D, Jicha GA, Ohm T, Weaver C. Dendritic changes in Alzheimer's disease and factors that may underlie these changes Progress in Neurobiology. 55: 595-609. PMID 9670220 DOI: 10.1016/S0301-0082(98)00022-7  0.766
1998 Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 393: 702-5. PMID 9641683 DOI: 10.1038/31508  0.603
1998 Davies P, Resnick J, Resnick B, Gilman S, Growdon JH, Khachaturian ZS, Radebaugh TS, Roses AD, Selkoe DJ, Trojanowski JQ, Blass JP, Gibson GE, Sheu KFR, Blennow K, Delacourte A, et al. Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease' Neurobiology of Aging. 19: 109-116. PMID 9558143 DOI: 10.1016/S0197-4580(98)00022-0  0.564
1997 Jicha GA, Lane E, Vincent I, Otvos L, Hoffmann R, Davies P. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. Journal of Neurochemistry. 69: 2087-95. PMID 9349554 DOI: 10.1046/J.1471-4159.1997.69052087.X  0.703
1997 Mizukami K, Ikonomovic MD, Grayson DR, Rubin RT, Warde D, Sheffield R, Hamilton RL, Davies P, Armstrong DM. Immunohistochemical study of GABA(A) receptor beta2/3 subunits in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes. Experimental Neurology. 147: 333-45. PMID 9344558 DOI: 10.1006/Exnr.1997.6591  0.313
1997 Ikonomovic MD, Mizukami K, Davies P, Hamilton R, Sheffield R, Armstrong DM. The loss of GluR2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer brains. Journal of Neuropathology and Experimental Neurology. 56: 1018-27. PMID 9291943 DOI: 10.1097/00005072-199709000-00007  0.347
1997 Vincent I, Mattiace LA, Dickson DW, Rosado M, Katen R, Davies P. TG-1: a marker for neuronal nuclei in Alzheimer's disease. Neurobiology of Disease. 1: 145-57. PMID 9173994 DOI: 10.1006/Nbdi.1994.0018  0.441
1997 Jicha GA, Bowser R, Kazam IG, Davies P. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. Journal of Neuroscience Research. 48: 128-32. PMID 9130141 DOI: 10.1002/(Sici)1097-4547(19970415)48:2<128::Aid-Jnr5>3.0.Co;2-E  0.752
1997 Shafit-Zagardo B, Kalcheva N, Dickson D, Davies P, Kress Y. Distribution and subcellular localization of high-molecular-weight microtubule-associated protein-2 expressing exon 8 in brain and spinal cord. Journal of Neurochemistry. 68: 862-73. PMID 9003079 DOI: 10.1046/J.1471-4159.1997.68020862.X  0.307
1996 Dickson DW, Feany MB, Yen SH, Mattiace LA, Davies P. Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration. Journal of Neural Transmission. Supplementum. 47: 31-46. PMID 8841955 DOI: 10.1007/978-3-7091-6892-9_2  0.426
1996 Schoonover S, Davies P, Bowser R. Immunolocalization and redistribution of the FAC1 protein in Alzheimer's disease. Journal of Neuropathology and Experimental Neurology. 55: 444-55. PMID 8786404 DOI: 10.1097/00005072-199604000-00007  0.668
1996 Vincent I, Rosado M, Davies P. Mitotic mechanisms in Alzheimer's disease? The Journal of Cell Biology. 132: 413-25. PMID 8636218 DOI: 10.1083/JCB.132.3.413  0.442
1996 Ksiezak-Reding H, Leibowitz RL, Bowser R, Davies P. Binding of Alz 50 depends on Phe8 in tau synthetic peptides and varies between native and denatured tau proteins. Brain Research. 697: 63-75. PMID 8593596 DOI: 10.1016/0006-8993(95)00785-O  0.683
1996 Edelmann W, Zervas M, Costello P, Roback L, Fischer I, Hammarback JA, Cowan N, Davies P, Wainer B, Kucherlapati R. Neuronal abnormalities in microtubule-associated protein 1B mutant mice. Proceedings of the National Academy of Sciences of the United States of America. 93: 1270-5. PMID 8577753 DOI: 10.1073/Pnas.93.3.1270  0.364
1996 Xuereb JH, MacMillan JC, Snell R, Davies P, Harper PS. Neuropathological diagnosis and CAG repeat expansion in Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 60: 78-81. PMID 8558157 DOI: 10.1136/jnnp.60.1.78  0.337
1995 Dickson DW, Davies P, Bevona C, Van Hoeven KH, Factor SM, Grober E, Aronson MK, Crystal HA. Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathologica. 88: 212-21. PMID 7810292 DOI: 10.1007/Bf00293396  0.394
1995 MacMillan JC, Davies P, Harper PS. Molecular diagnostic analysis for Huntington's disease: a prospective evaluation. Journal of Neurology, Neurosurgery, and Psychiatry. 58: 496-8. PMID 7738566 DOI: 10.1136/jnnp.58.4.496  0.308
1995 Bowser R, Giambrone A, Davies P. FAC1, a novel gene identified with the monoclonal antibody Alz50, is developmentally regulated in human brain. Developmental Neuroscience. 17: 20-37. PMID 7621746 DOI: 10.1159/000111270  0.61
1995 Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, Davies P. Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiology of Aging. 16: 285-98; discussion 2. PMID 7566338 DOI: 10.1016/0197-4580(95)00013-5  0.377
1995 Bowser R, Giambrone A, Davies P. FAC1, a Novel Gene Identified with the Monoclonal Antibody Alz50, Is Developmentally Regulated in Human Brain (Part 2 of 2) Developmental Neuroscience. 17: 30-37. DOI: 10.1159/000315743  0.635
1995 Davies P, Vincent IJ. On the role of tau phosphorylation in the formation of PHF Neurobiology of Aging. 16: 420-422. DOI: 10.1016/0197-4580(95)00039-H  0.398
1994 Simpson IA, Davies P. Reduced glucose transporter concentrations in brains of patients with Alzheimer's disease. Annals of Neurology. 36: 800-1. PMID 7979229 DOI: 10.1002/ANA.410360522  0.327
1994 Davies P. Strategies for the development of therapeutics for Alzheimer's disease Neurobiology of Aging. 15: 53-54. PMID 7700461 DOI: 10.1016/0197-4580(94)90169-4  0.364
1994 Vincent I, Rosado M, Kim E, Davies P. Increased production of paired helical filament epitopes in a cell culture system reduces the turnover of tau. Journal of Neurochemistry. 62: 715-23. PMID 7507514 DOI: 10.1046/j.1471-4159.1994.62020715.x  0.455
1993 Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P, MacDonald ME, Gusella JF, Harper PS, Shaw DJ. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nature Genetics. 4: 393-7. PMID 8401588 DOI: 10.1038/Ng0893-393  0.313
1993 Arias C, Sharma N, Davies P, Shafit-Zagardo B. Okadaic acid induces early changes in microtubule-associated protein 2 and tau phosphorylation prior to neurodegeneration in cultured cortical neurons. Journal of Neurochemistry. 61: 673-82. PMID 8336148 DOI: 10.1111/j.1471-4159.1993.tb02172.x  0.401
1993 Rye DB, Leverenz J, Greenberg SG, Davies P, Saper CB. The distribution of Alz-50 immunoreactivity in the normal human brain. Neuroscience. 56: 109-27. PMID 8232910 DOI: 10.1016/0306-4522(93)90567-Y  0.428
1993 Honer WG, Hu L, Davies P. Human synaptic proteins with a heterogeneous distribution in cerebellum and visual cortex. Brain Research. 609: 9-20. PMID 7685234 DOI: 10.1016/0006-8993(93)90848-H  0.308
1993 Davies P. Alz 50 as a reagent to assess animal models of Alzheimer's disease. Neurobiology of Aging. 13: 613-4. PMID 1461351 DOI: 10.1016/0197-4580(92)90066-7  0.318
1993 Dickson DW, Ksiezak-Reding H, Liu WK, Davies P, Crowe A, Yen SH. Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site. Acta Neuropathologica. 84: 596-605. PMID 1281953 DOI: 10.1007/Bf00227736  0.417
1992 Honer WG, Kaufmann CA, Davies P. Characterization of a synaptic antigen of interest in neuropsychiatric illness. Biological Psychiatry. 31: 147-58. PMID 1737076 DOI: 10.1016/0006-3223(92)90201-A  0.304
1992 Honer WG, Dickson DW, Gleeson J, Davies P. Regional synaptic pathology in Alzheimer's disease Neurobiology of Aging. 13: 375-382. PMID 1625766 DOI: 10.1016/0197-4580(92)90111-A  0.398
1992 Licameli V, Mattiace LA, Erlichman J, Davies P, Dickson D, Shafit-Zagardo B. Regional localization of the regulatory subunit (RII beta) of the type II cAMP-dependent protein kinase in human brain. Brain Research. 578: 61-8. PMID 1511290 DOI: 10.1016/0006-8993(92)90230-7  0.388
1992 Weber SJ, Louis RB, Trombley L, Bissette G, Davies P, Davis TP. Metabolic half-life of somatostatin and peptidase activities are altered in Alzheimer's disease. Journal of Gerontology. 47: B18-25. PMID 1346149 DOI: 10.1093/Geronj/47.1.B18  0.312
1992 Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen SH, Aronson MK. Identification of normal and pathological aging in prospectively studied nondemented elderly humans Neurobiology of Aging. 13: 179-189. PMID 1311804 DOI: 10.1016/0197-4580(92)90027-U  0.405
1991 Vincent IJ, Davies P. Phosphorylation characteristics of the A68 protein in Alzheimer's disease. Brain Research. 531: 127-35. PMID 2126970 DOI: 10.1016/0006-8993(90)90765-4  0.339
1991 Byne W, Mattiace L, Kress Y, Davies P. Alz-50 immunoreactivity in the hypothalamus of the normal and Alzheimer human and the rat. The Journal of Comparative Neurology. 306: 602-12. PMID 2071697 DOI: 10.1002/CNE.903060406  0.399
1991 Davies P. Therapy for Alzheimer's disease: choosing a target. Clinical Neuropharmacology. S24-33. PMID 1913707 DOI: 10.1097/00002826-199114001-00005  0.35
1991 Mattiace LA, Kress Y, Davies P, Ksiezak-Reding H, Yen SH, Dickson DW. Ubiquitin-immunoreactive dystrophic neurites in Down's syndrome brains. Journal of Neuropathology and Experimental Neurology. 50: 547-59. PMID 1654399 DOI: 10.1097/00005072-199109000-00003  0.334
1991 Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress Y, Yen SH. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology. 41: 1402-9. PMID 1653914 DOI: 10.1212/Wnl.41.9.1402  0.416
1991 Peder Flaten T, Garruto R, Davies P, Weiner M, Ray Holleman D, Richard Goldstone J, Andrews D, Crapper Mclachlan D, Dalton A, Kruck T, Bell M, Smith W, Kalow W. Desferrioxamine for Alzheimer's disease The Lancet. 338: 324-326. DOI: 10.1016/0140-6736(91)90472-2  0.385
1990 Jagust WJ, Davies P, Tiller-Borcich JK, Reed BR. Focal Alzheimer's disease. Neurology. 40: 14-9. PMID 2296360 DOI: 10.1212/WNL.40.1.14  0.386
1990 Mattiace LA, Davies P, Yen SH, Dickson DW. Microglia in cerebellar plaques in Alzheimer's disease Acta Neuropathologica. 80: 493-498. PMID 2251906 DOI: 10.1007/Bf00294609  0.394
1990 Ghanbari HA, Miller BE, Haigler HJ, Arato M, Bissette G, Davies P, Nemeroff CB, Perry EK, Perry R, Ravid R. Biochemical assay of Alzheimer's disease--associated protein(s) in human brain tissue. A clinical study. Jama. 263: 2907-10. PMID 2187102 DOI: 10.1001/Jama.1990.03440210057032  0.429
1990 Crystal HA, Dickson DW, Lizardi JE, Davies P, Wolfson LI. Antemortem diagnosis of diffuse Lewy body disease. Neurology. 40: 1523-8. PMID 2170865 DOI: 10.1212/Wnl.40.10.1523  0.381
1990 Vincent IJ, Davies P. ATP-induced loss of Alz-50 immunoreactivity with the A68 proteins from Alzheimer brain is mediated by ubiquitin. Proceedings of the National Academy of Sciences of the United States of America. 87: 4840-4844. PMID 2162059 DOI: 10.1073/Pnas.87.12.4840  0.302
1990 Dickson DW, Wertkin A, Mattiace LA, Fier E, Kress Y, Davies P, Yen SH. Ubiquitin immunoelectron microscopy of dystrophic neurites in cerebellar senile plaques of Alzheimer's disease. Acta Neuropathologica. 79: 486-93. PMID 2158201 DOI: 10.1007/Bf00296107  0.464
1990 Greenberg SG, Davies P. A preparation of Alzheimer paired helical filaments that displays distinct τ proteins by polyacrylamide gel electrophoresis Proceedings of the National Academy of Sciences of the United States of America. 87: 5827-5831. PMID 2116006 DOI: 10.1073/pnas.87.15.5827  0.401
1989 Dickson DW, Crystal H, Mattiace LA, Kress Y, Schwagerl A, Ksiezak-Reding H, Davies P, Yen SH. Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathologica. 78: 572-84. PMID 2683563 DOI: 10.1007/Bf00691284  0.369
1989 Davies P. A different view of A68 and amyloid Neurobiology of Aging. 10: 408-409. PMID 2682319 DOI: 10.1016/0197-4580(89)90078-X  0.323
1989 Dickson D, Schwagerl A, Ksiezak-Reding H, Davies P, Yen S-. ALZHEIMER CHANGES IN DIFFUSE LEWY BODY DISEASE (LBD) Journal of Neuropathology and Experimental Neurology. 48: 380. DOI: 10.1097/00005072-198905000-00243  0.33
1988 Scicutella A, Davies P. Characterization of monoclonal antibodies to galactolipids and uses in studies of dementia. Journal of Neuropathology and Experimental Neurology. 47: 406-19. PMID 3385437 DOI: 10.1097/00005072-198807000-00002  0.366
1988 Hyman BT, Van Hoesen GW, Wolozin BL, Davies P, Kromer LJ, Damasio AR. Alz-50 antibody recognizes Alzheimer-related neuronal changes. Annals of Neurology. 23: 371-9. PMID 3382173 DOI: 10.1002/ana.410230410  0.534
1988 Hansen LA, DeTeresa R, Davies P, Terry RD. Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease. Neurology. 38: 48-54. PMID 3336463 DOI: 10.1212/Wnl.38.1.48  0.616
1988 Scicutella A, Davies P. Marked loss of cerebral galactolipids in Pick's disease. Annals of Neurology. 22: 606-9. PMID 3322183 DOI: 10.1002/ANA.410220508  0.372
1988 Cork LC, Powers RE, Selkoe DJ, Davies P, Geyer JJ, Price DL. Neurofibrillary tangles and senile plaques in aged bears. Journal of Neuropathology and Experimental Neurology. 47: 629-41. PMID 3171607 DOI: 10.1097/00005072-198811000-00006  0.394
1988 Wolozin B, Scicutella A, Davies P. Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America. 85: 6202-6206. PMID 2970636 DOI: 10.1073/Pnas.85.16.6202  0.389
1988 Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Annals of Neurology. 23: 138-44. PMID 2897823 DOI: 10.1002/Ana.410230206  0.603
1988 Doebler JA, Markesbery WR, Anthony A, Davies P, Scheff SW, Rhoads RE. Neuronal RNA in relation to Alz-50 immunoreactivity in Alzheimer's disease. Annals of Neurology. 23: 20-4. PMID 2449843 DOI: 10.1002/Ana.410230105  0.368
1987 Thal LJ, Davies P. Detection of antigens in Alzheimer cerebrospinal fluid by monoclonal antibodies. Journal of the American Geriatrics Society. 35: 1047-50. PMID 3680836 DOI: 10.1111/j.1532-5415.1987.tb04919.x  0.374
1987 Wolozin B, Davies P. Alzheimer-related neuronal protein A68: Specificity and distribution Annals of Neurology. 22: 521-526. PMID 3435070 DOI: 10.1002/Ana.410220412  0.392
1987 Dickson DW, Davies P, Mayeux R, Crystal H, Horoupian DS, Thompson A, Goldman JE. Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients. Acta Neuropathologica. 75: 8-15. PMID 3434218 DOI: 10.1007/Bf00686786  0.407
1987 Davies P. The genetics of Alzheimer's disease: a review and a discussion of the implications. Neurobiology of Aging. 7: 459-66. PMID 2951608 DOI: 10.1016/0197-4580(86)90071-0  0.367
1987 Mehler MF, Horoupian DS, Davies P, Dickson DW. Reduced somatostatin-like immunoreactivity in cerebral cortex in nonfamilial dysphasic dementia. Neurology. 37: 1448-53. PMID 2888051 DOI: 10.1212/Wnl.37.9.1448  0.362
1987 Terry RD, Hansen LA, DeTeresa R, Davies P, Tobias H, Katzman R. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. Journal of Neuropathology and Experimental Neurology. 46: 262-8. PMID 2881985 DOI: 10.1097/00005072-198705000-00003  0.598
1987 Dickson DW, Ksiezak-Reding H, Davies P, Yen SH. A monoclonal antibody that recognizes a phosphorylated epitope in Alzheimer neurofibrillary tangles, neurofilaments and tau proteins immunostains granulovacuolar degeneration Acta Neuropathologica. 73: 254-258. PMID 2441560 DOI: 10.1007/Bf00686619  0.457
1986 Dickson DW, Horoupian DS, Thal LJ, Davies P, Walkley S, Terry RD. Klüver-Bucy syndrome and amyotrophic lateral sclerosis: a case report with biochemistry, morphometrics, and Golgi study. Neurology. 36: 1323-9. PMID 3762937 DOI: 10.1212/Wnl.36.10.1323  0.548
1986 Wolozin BL, Pruchnicki A, Dickson DW, Davies P. A neuronal antigen in the brains of Alzheimer patients Science. 232: 648-650. PMID 3083509 DOI: 10.1097/00002093-198701000-00007  0.399
1986 Dickson DW, Yen SH, Suzuki KI, Davies P, Garcia JH, Hirano A. Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathologica. 71: 216-23. PMID 2432750 DOI: 10.1007/Bf00688042  0.4
1985 Thal LJ, Sharpless NS, Rosenbaum D, Davies P, Amin IM, Waltz JM. Ventricular fluid somatostatin concentration decreases in childhood-onset dystonia. Neurology. 35: 1742-6. PMID 2866469 DOI: 10.1212/WNL.35.12.1742  0.312
1985 Yen SH, Reding H, Davies P, Ciment G. The compositions of neurofibrillary tangles of the senile dementia of the Alzheimer type: An immunological study Annals of the New York Academy of Sciences. 455: 819-825. DOI: 10.1111/J.1749-6632.1985.Tb50487.X  0.388
1985 Davies P. Is it possible to design rational treatments for the symptoms of Alzheimer's disease? Drug Development Research. 5: 69-76. DOI: 10.1002/Ddr.430050107  0.322
1984 Horoupian DS, Thal L, Katzman R, Terry RD, Davies P, Hirano A, DeTeresa R, Fuld PA, Petito C, Blass J. Dementia and motor neuron disease: morphometric, biochemical, and Golgi studies. Annals of Neurology. 16: 305-13. PMID 6148912 DOI: 10.1002/Ana.410160306  0.589
1983 Davies P. The neurochemistry of Alzheimer's disease and senile dementia Medicinal Research Reviews. 3: 221-236. PMID 6136637 DOI: 10.1002/Med.2610030302  0.379
1982 Fuld PA, Katzman R, Davies P, Terry RD. Intrusions as a sign of Alzheimer dementia: chemical and pathological verification. Annals of Neurology. 11: 155-9. PMID 7073248 DOI: 10.1002/ana.410110208  0.563
1982 Crystal HA, Davies P. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type. Journal of Neurochemistry. 38: 1781-4. PMID 6176686 DOI: 10.1111/j.1471-4159.1982.tb06665.x  0.395
1982 Terry RD, Davies P, DeTeresa R, Katzman R. ARE BOTH PLAQUES AND TANGLES REQUIRED TO MAKE IT ALZHEIMERʼS DISEASE? Journal of Neuropathology and Experimental Neurology. 41: 364. DOI: 10.1097/00005072-198205000-00078  0.597
1981 Davies P, Terry RD. Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type. Neurobiology of Aging. 2: 9-14. PMID 6115327 DOI: 10.1016/0197-4580(81)90053-1  0.604
1980 Terry RD, Davies P. Dementia of the Alzheimer type. Annual Review of Neuroscience. 3: 77-95. PMID 6251745 DOI: 10.1146/  0.612
1980 Davies P, Katzman R, Terry RD. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature. 288: 279-80. PMID 6107862 DOI: 10.1038/288279a0  0.634
1980 Davies P, Kress Y, Terry RD. AUTORADIOGRAPHIC DEMONSTRATION OF MUSCARINIC RECEPTORS IN HUMAN BRAIN Journal of Neuropathology and Experimental Neurology. 39: 348. DOI: 10.1097/00005072-198005000-00043  0.501
1979 Davies P. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Research. 171: 319-27. PMID 37989 DOI: 10.1016/0006-8993(79)90336-6  0.345
1978 Davies P. Loss of Choline Acetyltransferase Activity in Normal Aging and in Senile Dementia Advances in Experimental Medicine and Biology. 113: 251-256. PMID 753090 DOI: 10.1007/978-1-4684-8893-7_16  0.332
1978 Davies P, Verth AH. Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains. Brain Research. 138: 385-92. PMID 589485 DOI: 10.1016/0006-8993(77)90758-2  0.348
1977 Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet (London, England). 2: 1403. PMID 63862 DOI: 10.1016/S0140-6736(76)91936-X  0.365
Show low-probability matches.